Clinical Trial

Aurora: AI-Based Narrative Intervention to Support Emotional Well-Being in Clinical and Non-Clinical Populations

Study acronym: Aurora
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 27, 2026 (before its estimated April 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Aurora is an interdisciplinary project evaluating a chatbot-mediated supportive care intervention designed to promote emotional expression, autobiographical meaning-making, identity processes, and emotional well-being through guided narrative reconstruction. The Aurora system provides a structured, person-centered storytelling process supported by generative AI and human facilitation. Under the supervision of a trained facilitator (licensed mental health professional), participants engage in guided reminiscence and storytelling sessions to co-create a personalized "life book." The chatbot is not a diagnostic or treatment tool; rather, it is intended to support emotional expression, narrative reconstruction, and recovery-oriented processes. The study includes three non-randomized arms implemented sequentially: (1) a single-session arm of healthy adults focused on acceptability, usability, and emotional safety; (2) a four-hour intervention arm of adults with DSM-5 diagnosed mental disorders in residential care; and (3) a four-hour intervention arm of healthy older adults aged 65 years and older. Quantitative outcomes assess affect, mental well-being, and recovery-related constructs. Additional measures include usability, satisfaction, and qualitative feedback. Ecological momentary assessment (EMA) is conducted in Arms 2 and 3.
Trial Details
NCT Number NCT07494110
Lead Sponsor Universitat Autonoma de Barcelona
Collaborators: Grup ATRA, AGAUR, Institut Municipal de Persones amb Discapacitat, Parc Sanitari Sant Joan de Déu, Universitat Oberta de Catalunya
Conditions Institutionalization, Elderly, Mental Health, Wellbeing, Aging
Enrollment 55 participants
Start Date 2026-02-12
Primary Completion 2026-04-01 (estimated)
Study Completion 2026-04-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-27